Please assess the completion status of the following clinical trial:

Trial Title: A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* unresectable stage IIIB or IV NSCLC~* adequate bone marrow, hepatic, thyroid and renal function~Exclusion Criteria:~* peripheral neuropathy \>= grade 2~* gastrointestinal abnormalities~* known hypersensitivity to retinoids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bexarotene (Type: EXPERIMENTAL): Bexarotene oral capsules will be administered daily beginning on the initial day of chemotherapy (day 1).

Based on this trial design, predict the completion outcome and termination type (if applicable).